close

Enter

Log in using OpenID

Rivaroxaban Market to Surpass US$ 7.0 Billion by 2026

embed
Increasing number of hip and knee replacement surgeries are augmenting rivaroxaban market growth
Rivaroxaban Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Rivaroxaban Market – Overview
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto.
Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and
potentially life-threatening conditions associated with blood coagulation. Rivaroxaban was discovered by Bayer
and is being jointly developed with Janssen Research & Development, LLC.
Xarelto is approved for indications such as stroke prevention in non-valvular atrial fibrillation, pulmonary
embolism, deep vein thrombosis, prevention of recurrent venous thromboembolism (VTE), prevention of VTE
after elective hip and knee replacement surgery, and secondary prevention after acute coronary syndrome.
In September 2008, the drug received CE approval for venous thromboembolism in adults undergoing knee and
hip replacement surgeries and in 2011, it was approved by the U.S. Food and Drug Administration (FDA) for the
same indication. Xarelto is approved in over 130 countries by respective regulatory bodies.
REPORT DESCRIPTION
Rivaroxaban Market Taxonomy:
By Strength:
10 mg
15 mg
20 mg
By Application:
Deep Vein Thrombosis Prophylaxis
Pulmonary Embolism
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1962
REPORT DESCRIPTION
Rivaroxaban Market – Key Players
Major players operating in the global rivaroxaban market include Janssen Pharmaceuticals Inc. and Bayer
AG.
Market players strategize to strengthen their foot hold in the market in spite of high cost by implementing
cost-effective treatment schemes. For instance, Janssen Pharmaceuticals offer Xarelto manufacturer coupon
or patient assistance program to lower the cost of the drug.
Dreadful injuries caused due to Xarelto, has led the company face many legal issues in the U.S. market. For
instance, as of January 30, 2018, Bayer Group had been served in the U.S. with around 22,000 claims of
Xarelto for personal injuries from the use of Xarelto, which includes cerebral, gastrointestinal or other
bleeding and death causes. On clearance of the claims, the market of the product is expected to be affected
in terms of revenue.
Get More Inf @ https://www.coherentmarketinsights.com/market-insight/rivaroxaban-market-1962
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
Author
abhijit
abhijit125   documents Email
1/--pages
Report inappropriate content